Compound comparison
A structured research comparison between Thymosin Alpha 1 and SS-31 across compound identity, research category, evidence maturity, and interpretation boundaries.
Thymic immune-signaling peptide
Investigated in innate and adaptive immune signaling across preclinical and clinical contexts.
Substantial clinical evidence
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
Mitochondria-targeted tetrapeptide
Investigated in mitochondrial membrane, cardiolipin, redox, and organ-specific mitochondrial dysfunction models.
Developing clinical evidence
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
| Dimension | Thymosin Alpha 1 | SS-31 |
|---|---|---|
| Catalog identity | Thymosin Alpha 1 is mapped to thymic immune-signaling peptide research. | SS-31 is mapped to mitochondria-targeted peptide research. |
| Research category | Thymosin Alpha 1 is primarily organized around immune modulation and clinical-translational literature. | SS-31 is primarily organized around mitochondrial dysfunction and cardiolipin-context research. |
| Interpretive boundary | Use the Thymosin Alpha 1 profile and verified study pages before inferring mechanism or outcomes. | Use the SS-31 profile and verified study pages before inferring mechanism or outcomes. |
Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.
Thymosin alpha 1 literature index
PubMed, U.S. National Library of Medicine · Database
Atlas internal research database
Internal Research Database · 2026 · Database
SS-31 and elamipretide literature index
PubMed, U.S. National Library of Medicine · Database
Continue the research map